TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Mallinckrodt to acquire Sucampo Pharmaceuticals in $1.2bn deal In a strategic move to broaden its pharmaceutical offerings, UK-based Mallinckrodt has announced the acquisition of Sucampo Pharmaceuticals,… bySrinathDecember 26, 2017
